Article thumbnail

Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy

By 
Publisher: BioMed Central
Year: 2016
DOI identifier: 10.1186/s40425-016-0177-2
OAI identifier:

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.